Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell KillingChan Gyu Lee, Young Kee Shin|Frontiers in Pharmacology|2021Cited by 12